Target Name: GPR142
NCBI ID: G350383
Review Report on GPR142 Target / Biomarker Content of Review Report on GPR142 Target / Biomarker
GPR142
Other Name(s): GPR142 variant 2 | Probable G-protein coupled receptor 142 (isoform a) | Probable G-protein coupled receptor 142 | PGR2 | G-protein coupled receptor 142 long form | GP142_HUMAN | G protein-coupled receptor 142 (GPR142) | Probable G-protein coupled receptor 142 (isoform b) | GPR142 variant 1 | G-protein coupled receptor PGR2 | G protein-coupled receptor 142, transcript variant 1 | GPRg1b | G protein-coupled receptor 142, transcript variant 2 | G protein-coupled receptor 142

Understanding GPR142: A Potential Drug Target and Biomarker for Diseases

GPR142 (GPR142 variant 2) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative disorders, and psychiatric conditions. Its unique genetic variation has led to a diverse expression profile, which has implications for its potential role in disease.

GPR142 is a gene that encodes a protein known as GPR142, which is a member of the G protein-coupled receptor (GPCR) family. GPCRs are a family of transmembrane proteins that play a crucial role in cellular signaling, including sensory perception, neurotransmission, and hormone signaling. GPR142 is expressed in many tissues and cells throughout the body and is involved in a variety of physiological processes, including cell survival, growth, and differentiation.

The GPR142 gene has been studied extensively due to its association with several diseases, including cancer, neurodegenerative disorders, and psychiatric conditions. GPR142 has been shown to be involved in several signaling pathways that are implicated in these diseases, including the regulation of cell survival, angiogenesis, and neurotransmission.

One of the most promising aspects of GPR142 is its potential as a drug target. GPR142 has been shown to play a role in a variety of diseases, including cancer, neurodegenerative disorders, and psychiatric conditions. For example, GPR142 has been shown to be involved in the regulation of cell survival and angiogenesis, which are important processes in the development and progression of these diseases. Additionally, GPR142 has been shown to play a role in neurotransmission and the regulation of sensory perception, which are important processes in the brain that are implicated in a variety of psychiatric conditions.

In addition to its potential as a drug target, GPR142 has also been shown to be a potential biomarker for several diseases. The expression of GPR142 has been shown to be associated with the development and progression of cancer, neurodegenerative disorders, and psychiatric conditions. Additionally, GPR142 has been shown to be involved in the regulation of cell survival and angiogenesis, which are important processes in the development and progression of these diseases.

GPR142 has also been shown to be involved in the regulation of neurotransmission and sensory perception, which are important processes in the brain that are implicated in a variety of psychiatric conditions. For example, GPR142 has been shown to play a role in the regulation of dopamine release, which is involved in the treatment of Parkinson's disease. Additionally, GPR142 has been shown to play a role in the regulation of serotonin release, which is involved in the treatment of depression and anxiety disorders.

In conclusion, GPR142 is a gene that has been identified as a potential drug target or biomarker for a variety of diseases. Its unique genetic variation and diverse expression profile make it an attractive target for research and development of new treatments. Further studies are needed to fully understand the role of GPR142 in disease and to develop safe and effective drugs that target this gene.

Protein Name: G Protein-coupled Receptor 142

Functions: Orphan receptor

The "GPR142 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPR142 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GPR143 | GPR146 | GPR148 | GPR149 | GPR15 | GPR150 | GPR151 | GPR152 | GPR153 | GPR155 | GPR156 | GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176 | GPR179 | GPR18 | GPR180 | GPR182 | GPR183 | GPR19 | GPR199P | GPR20 | GPR21 | GPR22 | GPR25 | GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34 | GPR35 | GPR37 | GPR37L1 | GPR39 | GPR4 | GPR42 | GPR45 | GPR50 | GPR52 | GPR55 | GPR6 | GPR61 | GPR62 | GPR63 | GPR65 | GPR68 | GPR75 | GPR75-ASB3 | GPR78 | GPR79 | GPR82 | GPR83 | GPR84 | GPR84-AS1 | GPR85 | GPR87 | GPR88 | GPR89A | GPR89B | GPRACR | GPRASP1 | GPRASP2 | GPRASP3 | GPRC5A | GPRC5B | GPRC5C | GPRC5D | GPRC5D-AS1 | GPRC6A | GPRIN1 | GPRIN2 | GPRIN3 | GPS, PLAT and transmembrane domain-containing protein | GPS1 | GPS2 | GPS2P1 | GPSM1 | GPSM2 | GPSM3 | GPT | GPT2 | GPX1 | GPX1P1 | GPX2 | GPX3 | GPX4 | GPX5 | GPX6 | GPX7